Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Azora Therapeutics, Inc.

Azora Therapeutics, Inc. (AZR) Stock Overview

Explore Azora Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AZR●NASDAQ
HealthcareMedical - Pharmaceuticals
$3.89
$0.08(2.10%)
U.S. Market opens in 4h 15m

Azora Therapeutics, Inc. (AZR)

Meyka AI Score

Z

Key Financials

Market Cap10.4M
P/E RatioN/A
EPS (TTM)$-16.54
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

AZR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Azora Therapeutics, Inc. (NASDAQ: AZR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Azora Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AZR on the NASDAQ shows an RSI of 100.00, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Azora Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 10.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AZR on the NASDAQ.

Price Performance (NASDAQ: AZR)

1-Day Change
4.20%
5-Day Change
-0.25%
1-Month Change
-3.64%
3-Month Change
-3.87%
6-Month Change
-3.87%
Year-to-Date (YTD) Change
-3.87%
1-Year Change
-3.87%
3-Year Change
-3.87%
5-Year Change
-3.87%
All-Time (Max) Change
-3.87%

Contact Information

https://azoratherapeutics.com
NaN
4870 Sadler Road, Suite 300, Glen Allen, VA, 23060

Company Facts

60 Employees
IPO DateJul 27, 2018
CountryUS
Actively Trading

Frequently Asked Questions